Comparison of 1-year recurrence-free survival between sevoflurane and propofol use for general anesthesia management in primary breast cancer surgery.

Shiono, Shinnosuke; Shibata, Sho C; Kabata, Daijiro; Shintani, Ayumi; Ikeda, Takehiko; Fujino, Yuji

Shiono, Shinnosuke; Shibata, Sho C; Kabata, Daijiro; Shintani, Ayumi; Ikeda, Takehiko; Fujino, Yuji.

Afiliação

Shiono S; Department of Anesthesiology, National Defense Medical College Hospital, Tokorozawa, Saitama, Japan.
Shibata SC; Department of Anesthesiology and Intensive Care Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0781, Japan. scshibata@anes.med.osaka-u.ac.jp.
Kabata D; Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Shintani A; Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Ikeda T; Department of Anesthesiology, National Defense Medical College Hospital, Tokorozawa, Saitama, Japan.
Fujino Y; Department of Anesthesiology and Intensive Care Medicine, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0781, Japan.

J Anesth ; 34(5): 694-701, 2020 10.

Article em En | MEDLINE | ID: mdl-32524294

Assuntos

Anestésicos Inalatórios; Neoplasias da Mama; Éteres Metílicos; Propofol; Anestesia Geral; Anestésicos Intravenosos; Neoplasias da Mama/cirurgia; Humanos; Estudos Retrospectivos; Sevoflurano

Palavras-chave

Breast cancer; Propofol; Recurrence; Sevoflurane

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Propofol / Anestésicos Inalatórios / Éteres Metílicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google